Should You Invest In Sberbank Rossii OAO – ADR(OTCMKTS:SBRCY), ZIOPHARM Oncology Inc.(NASDAQ:ZIOP), and bebe stores, inc.(NASDAQ:BEBE)?
New York, NY – GDP INSIDER – 12/05/2014.
This article discusses three companies: Sberbank Rossii OAO – ADR(OTCMKTS:SBRCY), ZIOPHARM Oncology Inc.(NASDAQ:ZIOP), and bebe stores, inc.(NASDAQ:BEBE)
Sberbank Rossii OAO – ADR(OTCMKTS:SBRCY) traded for as little as $5.50 yesterday, a new 52 week low for the company. Considering the fact that the company has a one-year target estimate of $11.60, the low closing price could be good news for investors who wish to purchase Sberbank of Russia OJSC shares. The company has a price to earnings ratio (TTM) of $2.75 and an earnings per share (TTM) of $2.00.
ZIOPHARM Oncology Inc.(NASDAQ:ZIOP) has traded within a range of $2.31 to $5.58 over the past 52 weeks, yet finished yesterday’s trading at a closing price of $3.83 after a 3.23% gain of twelve cents. The company has an earnings per share (TTM) of $–0.31 and a beta of 1.77, which indicates that the stock is 77% more volatile than the market. ZIOPHARM Oncology has a market capitalization of $392.19 million and a three month average trading volume of 0.99 million.
bebe stores, inc.(NASDAQ:BEBE) was in the headlines yesterday due to reports that hackers may have stolen payment card data from the company. The news sparked increased trader interest in the stock, as Bebe Stores had a trading volume of 0.81 million yesterday. This figure is 0.41 million higher than its three month average volume of 0.40 million. Bebe Stores has an earnings per share (TTM) of $–0.95, a beta of 2.39, and a dividend of $0.06.
HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.
Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.
Disclosure: HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.